COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Vasopressin - 1st Edition - ISBN: 9780128208168, 9780128208175

Vasopressin, Volume 113

1st Edition

Editor: Gerald Litwack
eBook ISBN: 9780128208175
Hardcover ISBN: 9780128208168
Imprint: Academic Press
Published Date: 3rd March 2020
Page Count: 328
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

1. Vasotocin and the origins of the vasopressin/oxytocin receptor gene family
Sally A. Mayasich and Benjamin L. Clarke
2. Oxytocin/vasopressin-like neuropeptide signaling in insects
Edin Muratspahić, Emilie Monjon, Leopold Dürrauer, Stephen M. Rogers, Darron A. Cullen, Jozef Vanden Broeck and Christian W. Gruber
3. Amyloid-like aggregation of provasopressin
Martin Spiess, Nicole Beuret, Cristina Prescianotto Baschong and Jonas Rutishauser
4. V2 vasopressin receptor mutations
Noriko Makita, Katsunori Manaka and Taroh Iiri
5. Vasopressin inactivation: Role of insulin-regulated aminopeptidase
Don T. Li, Estifanos N. Habtemichael and Jonathan S. Bogan
6. Molecular aspects of aquaporins
Suchun Li, Chunling Li and Weidong Wang
7. The vasotocinergic system and its role in the regulation of stress in birds
Wayne J. Kuenzel, Seong W. Kang and Alexander Jurkevich
8. Vasopressin actions in the kidney renin angiotensin system and its role in hypertension and renal disease
Alexis A. Gonzalez, Nicolas Salinas-Parra, Flavia Cifuentes-Araneda and Cristian Reyes-Martinez
9. Vasopressin receptor subtypes and renal sodium transport
Yu. V. Natochin and D. V. Golosova
10. Development and therapeutic potential of vasopressin synthetic analog [V4Q5]dDAVP as a novel anticancer agent
Garona Juan, Pifano Marina, Ripoll Giselle and Alonso Daniel F.
11. Vasopressin and vasopressin receptors in brain edema
Emil Zeynalov, Susan M. Jones and J. Paul Elliott


Vasopressin, Volume 113 in the Vitamins and Hormones series, highlights new advances in the field, with this new volume presenting updates on timely topics, including Diabetes Insipidus in Pregnancy, Vasopressin Inactivation: Role of Insulin-Regulated Aminopeptidase, Vasotocin and the Origins of the Vasopressin/Oxytocin Receptor Gene Family, Vasopressin V2 Receptor Ligand Recognition, Development and Therapeutic Potential of Vasopressin Synthetic Analog [V4Q5]dDAVP as a Novel Anticancer Agent, Cellular Junctions and Vasopressin, Vasopressin Actions in the Kidney Renin Angiotensin System and its Role in Hypertension and Renal Disease, Oxytocin/Vasopressin-Like Neuropeptide Signaling in Insects, and much more.

Key Features

  • Provides the authority and expertise of leading contributors from an international board of authors
  • Presents the latest release in the Vitamins and Hormones series
  • Includes the latest information on Vasopressin


Undergraduates, graduates, academics and researchers in the field of vitamins and hormones


No. of pages:
© Academic Press 2020
3rd March 2020
Academic Press
eBook ISBN:
Hardcover ISBN:

Ratings and Reviews

About the Editor

Gerald Litwack

Gerald Litwack

Dr. Gerald Litwack obtained M.S. and PhD degrees from the University of Wisconsin Department of Biochemistry and remained there for a brief time as a Lecturer on Enzymes. Then he entered the Biochemical Institute of the Sorbonne as a Fellow of the National Foundation for Infantile Paralysis. He next moved to Rutgers University as an Assistant Professor of Biochemistry and later as Associate Professor of biochemistry at the University of Pennsylvania Graduate School of Medicine. After four years he moved to the Temple University School of Medicine as Professor of Biochemistry and Deputy Director of the Fels Institute for Cancer Research and Molecular Biology, soon after, becoming the Laura H. Carnell Professor. Subsequently he was appointed chair of Biochemistry and Molecular Pharmacology at the Jefferson Medical College as well as Vice Dean for Research and Deputy Director of the Jefferson Cancer Institute and Director of the Institute for Apoptosis. Following the move of his family, he became a Visiting Scholar at the Department of Biological Chemistry of the Geffen School of Medicine at UCLA and then became the Founding Chair of the Department of Basic Sciences at the Geisinger Commonwealth School of Medicine, becoming Professor of Molecular and Cellular Medicine and Associate Director of the Institute for Regenerative Medicine at the Texas A&M Health Science Center as his final position. During his career he was a visiting scientist at the University of California, San Francisco and Berkeley, Courtauld Institute of Biochemistry, London and the Wistar Institute. He was appointed Emeritus Professor and/or Chair at Rutgers University, Thomas Jefferson University and the Geisinger Commonwealth School of Medicine. He has published more than 300 scientific papers, authored three textbooks and edited more than sixty-five books. Currently he lives with his family and continues his authorship and editorial work in Los Angeles.

Affiliations and Expertise

Toluca Lake, North Hollywood, California, USA